Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients.

Autor: Romero-Secin AA; Specialist in Family and Community Medicine, Colloto Health Clinic, Principality of Asturias Health Service, Asturias, Spain; Fundacion redGEDAPS, Spain., Díez-Espino J; Fundacion redGEDAPS, Spain; Specialist in Family and Community Medicine, Tafalla Health Center, Tafalla, Navarrese Health Service, Navarra, Spain., Prieto-Díaz MA; Specialist in Family and Community Medicine, Vallobín-La Florida Health Center, Principality of Asturias Health Service, Asturias, Spain., Pallares-Carratala V; Department of Medicine, Jaume I University, Castellon, Spain. Electronic address: pallares.vic@gmail.com., Barquilla-García A; Specialist in Family and Community Medicine, Trujillo Health Center, Extremadura Health Service, Cáceres, Spain., Micó-Pérez RM; Specialist in Family and Community Medicine, Fontanars dels Alforins Health Center, Xàtiva-Ontinyent Department of Health, Valencia, Spain., Polo-García J; Specialist in Family and Community Medicine, Casar de Cáceres Health Center, Extremadura Health Service, Cáceres, Spain., Velilla-Zancada SM; Specialist in Family and Community Medicine, Joaquin Elizalde Health Center, Rioja Health Service, Logroño, La Rioja, Spain., Martín-Sanchez V; Institute of Biomedicine (IBIOMED), University of León, Epidemiology and Public Health Networking Biomedical Research Centre (CIBERESP), León, Spain., Segura-Fragoso A; Epidemiology Unit, Semergen Research Agency, Madrid, Spain., Ginel-Mendoza L; Specialist in Family and Community Medicine, Ciudad Jardín Health Center, Málaga, Spain., Arce-Vazquez VM; Centro de investigación en medicina molecular y enfermedades crónicas (CIMUS), Universidad de Santiago de Compostela, Galicia, Spain., Cinza-Sanjurjo S; Specialist in Family and Community Medicine, Milladoiro Health Centre, Health Area of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), A Coruña, Spain; Networking Biomedical Research, Centre-Cardiovascular Diseases (CIBERCV), Santiago de Compostela, Spain.

Publikováno v: Semergen [Semergen] 2024 Sep; Vol. 50 (6), pp. 102220. Date of Electronic Publication: 2024 Mar 29.